Brian Rye Email & Phone Number

Atlanta Metropolitan Area

Washington D.C. Metro Area

Authored timely and insightful analysis on the impact of government legislation and regulation on the pharmaceutical, device, hospital and health insurance sectors. • Featured in multiple Bloomberg TV and radio programs; possess strong written and oral communication skills that have been honed via hundreds of reports and presentations to stakeholders around the world. Participant in keynote panels at multiple industry conferences (e.g., BIO, AICPA).• Delivered health-related policy research reports for Bloomberg subscribers. Examples of topics covered include drug-pricing reforms, surprise-billing issues, Affordable Care Act (ACA) legal challenges, and elections’ impact on the healthcare industry.

Washington D.C. Metro Area

Published full-length studies and shorter analytical reports assessing the impact of proposed legislation and regulation on the pharmaceutical and biotechnology sector.• Made multiple appearances on several television and radio shows. Moderated panels on healthcare topics at both Bloomberg and industry-sponsored events.• Authored studies on a variety of healthcare topics, including the Food and Drug Administration user fee reauthorization process, the ACA annual brand-name drug tax, and the 340B drug discount program.

Rockville, Maryland

Focused on healthcare issues via two distinct contracts for clients within the National Institutes of Health. • Supported the National Cancer Institute’s Office of Biorepositories and Biospecimen Research as well as the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Philadelphia, Pennsylvania

Served as senior biotechnology analyst, providing in-depth research coverage on 10-15 biopharmaceutical companies as well as broader industry overviews. Responsible for providing specific investment recommendations; published full-length reports, periodic research briefs and financial models.• Coverage universe included Genentech, ImClone Systems, Medarex, and ImmunoGen.• Subject of a Wall Street Journal story on analysts’ ratings of ImClone Systems, highlighting my contrarian and ultimately correct view on a high-profile stock.• Regularly quoted by Forbes, Fortune, Dow Jones, Reuters, Bloomberg News, and MarketWatch.

Nashville, Tennessee

Served as senior biotechnology analyst, authoring in-depth research coverage of over ten biopharmaceutical companies as well as broader industry overviews. Provided specific investment recommendations to both institutional and retail clients. Met with both biopharmaceutical executives as well as institutional and hedge-fund clients.• Spoke frequently to industry audiences and conducted many televised interviews, including CNBC’s Squawk Box.• Maintained coverage universe comprised of 10-15 development-stage biopharmaceutical companies, including Onyx Pharmaceuticals, Medarex, ImClone Systems, and Abgenix.

Nashville, Tennessee

Successfully initiated the firm’s coverage of the biopharmaceutical industry after promotion from junior healthcare services analyst. Introduced complex ideas to firm’s sales force and generated impressive returns for investors with picks (ImClone, Onyx, Abgenix).• Spoke frequently to industry audiences and conducted several televised interviews, including CNBC’s Power Lunch.• Built coverage universe comprised of eight development-stage biopharmaceutical companies.